These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15661552)

  • 1. The role of early expression of inducible nitric oxide synthase in human breast cancer.
    Loibl S; Buck A; Strank C; von Minckwitz G; Roller M; Sinn HP; Schini-Kerth V; Solbach C; Strebhardt K; Kaufmann M
    Eur J Cancer; 2005 Jan; 41(2):265-71. PubMed ID: 15661552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancer.
    Loibl S; Strank C; von Minckwitz G; Sinn HP; Buck A; Solbach C; Strebhardt K; Kaufmann M
    Breast; 2005 Jun; 14(3):230-5. PubMed ID: 15927832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy.
    Loibl S; von Minckwitz G; Weber S; Sinn HP; Schini-Kerth VB; Lobysheva I; Nepveu F; Wolf G; Strebhardt K; Kaufmann M
    Cancer; 2002 Sep; 95(6):1191-8. PubMed ID: 12216084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors.
    Reveneau S; Arnould L; Jolimoy G; Hilpert S; Lejeune P; Saint-Giorgio V; Belichard C; Jeannin JF
    Lab Invest; 1999 Oct; 79(10):1215-25. PubMed ID: 10532585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer.
    Zafirellis K; Zachaki A; Agrogiannis G; Gravani K
    APMIS; 2010 Feb; 118(2):115-24. PubMed ID: 20132175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients.
    Mortensen K; Holck S; Christensen IJ; Skouv J; Hougaard DM; Blom J; Larsson LI
    Clin Cancer Res; 1999 May; 5(5):1093-7. PubMed ID: 10353743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.
    Ambs S; Merriam WG; Bennett WP; Felley-Bosco E; Ogunfusika MO; Oser SM; Klein S; Shields PG; Billiar TR; Harris CC
    Cancer Res; 1998 Jan; 58(2):334-41. PubMed ID: 9443414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of women with node negative breast cancer in the Auckland region.
    Lethaby AE; Mason BH; Harvey VJ; Holdaway IM
    N Z Med J; 1996 Sep; 109(1029):330-3. PubMed ID: 8862351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
    Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
    J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer.
    Lipponen P; Saarelainen E; Ji H; Aaltomaa S; Syrjänen K
    J Pathol; 1994 Oct; 174(2):101-9. PubMed ID: 7965405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p53 protein has no independent prognostic value in breast cancer.
    Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
    J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
    MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
    Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
    Borgquist S; Jögi A; Pontén F; Rydén L; Brennan DJ; Jirström K
    Breast Cancer Res; 2008; 10(5):R79. PubMed ID: 18808688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients.
    Foekens JA; Look MP; Bolt-de Vries J; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Jan; 79(2):300-7. PubMed ID: 9888472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.